Obstetrix One

Prenatal Softgels Ingredients

The physician recommended, all-in-one prenatal softgel formulated to be well tolerated.

The power is in the folate

Obstetrix One's contains groundbreaking form of folate that is easier for the body to break down and pass along to the baby, protecting them from brain and spine defects as they develop.

Breakdown

Process

Folic acid needs to be converted by the body to its active form, L-Methylfolate (MTHF). Up to 75% of people in the world lack the enzyme necessary to fully metabolize folic acid into its active form1. That’s why we’ve chosen to include Metafolin (L-Methylfolate) as the source of folate in OBSTETRIX ONE.*

logo
Other
Key Benefits:

Slow-Release Iron

Helps prevent nausea and constipation that comes with traditional iron supplements*

Vitamin B6

Helps ward off nausea and morning sickness associated with pregnancy*

Omega-3 DHA

Promotes fetal brain, eye, and nervous system development*

Obstetrix One Ingredients

Obstetrix One Prenatal Softgels Supplement Facts

Serving Size: 1 Softgel
Amount
Per Serving 		% Daily
Value**
Vitamin C (as calcium ascorbate dihydrate) 18 mg 15%
Vitamin D (as cholecalciferol) 6.25 mcg 42%
Vitamin E (as d-alpha tocopheryl acetate) 10 mg 53%
Vitamin B6 (as pyridoxine HCI) 30 mg 1500%
Folate (as L-5-methylfolate, calcium salt) - Metafolin® (1mg folate) 1.7 mg DFE 283%
Vitamin B12 (as cyanocobalamin) 15 mcg 536%
Iron (as carbonyl iron) 38 mg 141%
Magnesium (as magnesium oxide) 15 mg 4%
Zinc (as zinc oxide) 20mg 154%
DHA (docosahexaenoic acid from algal oil) 225 mg *
† Daily Value not established
* * Daily Value for Pregnant and Lactating Women

No artificial colorants or dyes

IMPORTANT WARNING

Accidental overdose of products containing iron is a leading cause of fatal poisoning in children under the age of 6. Keep this product out of the reach of children. In case of an accidental overdose, call your doctor or a poison control center immediately.

De Mattia, E., & Toffoli, G. (2009). C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalization. European Journal of Cancer, 45(8), 1333-1351.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.